Arcturus Therapeutics Holdings Inc.

NASDAQ:ARCT

15.48 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q2
Revenue 38.81545.97632.59828.21243.3769.56579.729160.04913.36927.0935.2445.7942.4372.0012.1272.2382.3332.3222.6462.9683.31810.1534.357.5773.4232.3862.36712.9983.2963.7613.8410000000000000000000
Cost of Revenue -2.8580.9-5.4140.8150.852.66851.76822.28137.68838.18944.89330.73345.39845.67950.0522.38617.6997.9447.91711.9947.0537.2697.3244.8473.9694.2253.9414.3533.5633.7694.0010000000000000000000
Gross Profit 41.67345.07638.01227.39742.576-43.10327.961137.768-24.319-11.096-39.649-24.939-42.961-43.678-47.923-20.148-15.366-5.622-5.271-9.026-3.7352.884-2.9742.73-0.546-1.839-1.5748.645-0.267-0.008-0.160000000000000000000
Gross Profit Ratio 1.0740.981.1660.9710.982-4.5060.3510.861-1.819-0.41-7.561-4.304-17.629-21.828-22.531-9.003-6.586-2.421-1.992-3.041-1.1260.284-0.6840.36-0.16-0.771-0.6650.665-0.081-0.002-0.0420000000000000000000
Reseach & Development Expenses 39.13436.34253.57326.81751.07752.66851.76826.98137.68838.18944.89332.63345.39845.67950.0524.28617.6997.9447.91711.9947.0537.2697.3244.8473.9694.2253.94111.3561.0591.4432.064.4476.44.1823.3623.3352.8533.6833.594.9088.7575.9185.5224.6032.0670.3210.0750.0670.1190.231
General & Administrative Expenses 13.27612.31614.85112.50713.37713.22513.76211.8612.48810.99310.7310.80610.8610.0429.7439.0345.5724.424.1911.7913.8813.4563.5343.4413.818.2335.0982.6551.6462.0911.181.2861.2111.4021.4581.3251.1761.2021.2891.4361.2661.3481.7891.041.0690.8750.2390.1820.1450.198
Selling & Marketing Expenses 0-0.90-0.8150000000000000000000000000000000000000000000000
SG&A 13.27611.41614.85111.69213.37713.22513.76211.8612.48810.99310.7310.80610.8610.0429.7439.0345.5724.424.1911.7913.8813.4563.5343.4413.818.2335.0982.6551.6462.0911.181.2861.2111.4021.4581.3251.1761.2021.2891.4361.2661.3481.7891.041.0690.8750.2390.1820.1450.198
Other Expenses -2.858-3.88303.27400-0.556-0.2440000000000000000000-0.580.2320.2890.3930.360.3130.3340.4120.3140.2940.2880.3490.4830.5620.5650.5240000000
Operating Expenses 49.55247.75863.0138.50962.6964.93964.97438.59750.17649.18255.62343.43956.25855.72159.79333.3223.27112.36412.10813.78510.93410.72510.8588.2887.77912.4589.03913.1422.8923.8233.6336.0937.9245.9185.2324.9744.3235.1735.2286.82710.5857.8317.8355.6433.1361.1960.3140.2490.2640.429
Operating Income -10.737-2.682-30.412-11.112-19.314-55.37414.755121.452-36.807-22.089-50.379-37.645-53.821-53.72-57.666-31.082-20.938-10.042-9.462-10.817-7.616-0.572-6.508-0.711-4.356-10.072-6.672-0.144-2.892-3.823-3.633-6.093-7.924-5.918-5.232-4.974-4.323-5.173-5.228-6.827-10.585-7.831-7.835-5.643-3.136-1.196-0.314-0.249-0.264-0.429
Operating Income Ratio -0.277-0.058-0.933-0.394-0.445-5.7890.1850.759-2.753-0.815-9.607-6.497-22.085-26.847-27.111-13.888-8.975-4.325-3.576-3.645-2.295-0.056-1.496-0.094-1.273-4.221-2.819-0.011-0.877-1.016-0.9460000000000000000000
Total Other Income Expenses Net 3.6173.763.9636.8273.9853.40136.102-2.811.5410.526-0.79-1.018-0.263-0.8611.32-0.022-0.066-0.221-0.315-0.1720.183-0.113-0.376-0.0450.1030.1220.101-1.042-0.285-2.6130.1250.1760.1370.1520.1720.1040.0680.0640.0640.0330.0590.0570.0780.0010.008-0.143-0.063-0.046-0.019-0.011
Income Before Tax -7.12-17.366-26.449-8.311-15.329-51.97350.857118.642-35.266-21.563-51.169-38.664-54.084-54.581-56.346-31.104-21.004-10.263-9.777-10.989-7.433-0.685-6.884-1.011-4.253-9.95-6.571-1.186-2.528-3.679-3.508-5.917-7.787-5.766-5.06-4.87-4.255-5.109-5.164-6.794-10.526-7.774-7.757-5.643-3.128-1.339-0.377-0.295-0.283-0.44
Income Before Tax Ratio -0.183-0.378-0.811-0.295-0.353-5.4340.6380.741-2.638-0.796-9.758-6.673-22.193-27.277-26.491-13.898-9.003-4.42-3.695-3.702-2.24-0.067-1.583-0.133-1.242-4.17-2.776-0.091-0.767-0.978-0.9130000000000000000000
Income Tax Expense -0.217-0.150.3680.2620.8930.5770.1031.295-0.7650.5970.790.059-0.02-0.0951.7940.169-0.2190.095-0.1930.4690.0560.093-0.0850.304-0.19700.101-0.050.0270.0120.0120.010.0150.0220.0260.0170.0070.0140.0130.008-0.040.0060.0090.0610000.03300
Net Income -6.903-17.216-26.817-8.573-16.222-52.5550.754117.347-34.501-21.563-51.959-38.664-54.084-54.581-56.346-31.104-21.004-10.263-9.777-10.989-7.433-0.685-6.884-1.011-4.253-9.95-6.571-1.136-2.555-3.691-3.52-5.927-7.802-5.788-5.086-4.887-4.262-5.123-5.177-6.802-10.486-7.78-7.766-5.704-3.128-1.339-0.377-0.295-0.283-0.44
Net Income Ratio -0.178-0.374-0.823-0.304-0.374-5.4940.6370.733-2.581-0.796-9.908-6.673-22.193-27.277-26.491-13.898-9.003-4.42-3.695-3.702-2.24-0.067-1.583-0.133-1.242-4.17-2.776-0.087-0.775-0.981-0.9160000000000000000000
EPS 0.14-0.64-1-0.32-0.61-1.981.914.43-1.3-0.82-1.97-1.47-2.05-2.07-2.15-1.19-0.92-0.55-0.67-0.76-0.56-0.066-0.68-0.1-0.42-0.99-0.66-0.11-1.22-1.82-0.89-1.51-1.98-1.47-1.29-1.42-1.41-1.69-1.8-2.36-5.36-3.99-3.99-3.13-1.97-1.04-0.24-0.19-0.18-0.28
EPS Diluted 0.14-0.64-1-0.32-0.61-1.981.874.33-1.3-0.82-1.97-1.47-2.05-2.07-2.15-1.19-0.92-0.55-0.67-0.76-0.56-0.066-0.68-0.1-0.42-0.99-0.66-0.11-1.22-1.82-0.89-1.51-1.98-1.47-1.29-1.42-1.41-1.69-1.8-2.36-5.36-3.99-3.99-3.13-1.97-1.04-0.24-0.19-0.18-0.28
EBITDA -9.825-16.466-25.545-7.492-14.509-51.27315.333122.003-34.101-20.304-50.155-37.489-53.084-53.72-56.741-30.644-20.614-9.83-9.341-10.864-7.164-0.302-6.336-0.405-4.197-9.927-6.46-0.044-2.355-0.967-3.361-5.903-7.91-5.9-5.217-4.962-4.307-5.162-5.218-6.589-10.577-7.823-7.829-5.64-3.135-1.194-0.313-0.246-0.262-0.427
EBITDA Ratio -0.253-0.039-0.782-0.365-0.445-5.372-0.2370.783-2.689-0.802-9.608-6.524-22.188-27.01-26.292-13.693-8.975-4.245-3.638-3.66-2.2040.006-1.496-0.038-1.24-4.161-2.729-0.023-0.795-1.012-0.940000000000000000000